Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Primary Membranous Nephropathy
NCT06573411Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2024
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in primary membranous nephropathy (PMN), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Sep 2024; status: recruiting.
02
Drugs
finerenone
03
Conditions
primary membranous nephropathy (PMN)
Beyond the preview
Go deeper on NCT06573411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06573411.